Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease

NCT00180037 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Coenzyme Q10 Nanodispersion (Nanoquinone)
DRUG: Placebo

Sponsor

Technische Universität Dresden

Collaborators

[object Object]
[object Object]